News

Cigna announces new deal for copay caps on Eli Lilly and Novo Nordisk weight loss drugs
Cigna’s pharmacy benefits unit Evernorth said the deal will bring prices down for employers and their workers.
Evernorth Launches New Benefit Option That Drives Lower Net Cost for Weight Loss Medicines and Limits Patient Cost to No More Than $200 Per Month
Evernorth, the health services division of The Cigna Group (NYSE: CI) announced a first-of-its-kind pharmacy benefit offering that make weight loss medications WEGOVY® and ZEPBOUND® more available to ...
WISN 12 News2h
FDA crackdown on off-brand weight loss and diabetes drugs set to take effect
The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...
Cigna to offer $200 Wegovy, Zepbound weight-loss benefit
Cigna said on Wednesday it was launching an add-on to pharmacy benefit management plans in which patients could pay no more ...
Modern Healthcare2h
Cigna debuts GLP-1 copay cap
Cigna subsidiary Evernorth Health Services will authorize prior authorizations for GLP-1 weight-loss drugs under a new ...
Pharmaceutical Commerce5h
Noom to Sell Microdoses of Wegovy
The telehealth site will welcome its own small-dose, compounded version of semaglutide, which mimics the function of a GLP-1.
No Medicare coverage for obesity treatment? These are the states where it’s still available
As of late 2024, only 14 state Medicaid programs cover GLP-1 drugs like Wegovy, Saxenda, or Zepbound for the treatment of obesity. These states are: California, Connecticut, Indiana, Maryland, ...